22. もやもや病 Moyamoya disease Clinical trials / Disease details

臨床試験数 : 17 / 薬物数 : 22 - (DrugBank : 17) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 45

diseases per page:

Showing 1 to 10 of 17 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCTs071220048	29/08/2022	29/08/2022	Angiogenesis augmentation therapy for indirect revascularization of moyamoya disease using G-CSF	Angiogenesis augmentation therapy for indirect revascularization of moyamoya diseaseusing G-CSF - ED ...	Moyamoya disease Moyamoya disease, indirect revascularization, Granulocyte-Colony Stimulating Factor ...	G-CSF(75 micrograms/body) is applied intraoperatively to the indirect revascularization site, and G- ...	Morioka Motohiro	NULL	Recruiting	>= 20age old	<= 60age old	Both	5	Phase 1-2	Japan
2	ChiCTR2100050185	2021-08-23	2021-08-21	Effect of stellate ganglion block on intracranial vascular and prognosis in patients with Moyamoya d ...	Effect of stellate ganglion block on intracranial vascular and prognosis in patients with Moyamoya d ...	Moyamoya disease	SGB group:Ipsilateral stellate ganglion block was performed with 0.2% ropivacaine8ml;control group:R ...	The First Affiliated Hospital of Sun Yat-sen University	NULL	Pending	12	65	Both	SGB group:12;control group:12;	Phase 1	China
3	ChiCTR2100050015	2021-08-12	2021-08-15	Effect of stellate ganglion block on intracranial vascular and stress level in patients with Moyamoy ...	Effect of stellate ganglion block on intracranial vascular and stress level in patients with Moyamoy ...	Moyamoya disease	stellate ganglion group:1.5% lidocaineplanetary ganglion block; control group:DSA only, no stellate ...	the First Affiliated Hospital of Sun Yat-Sen University	NULL	Pending	12	65	Both	stellate ganglion group:12; control group:12;		China
4	ChiCTR2100046178	2021-05-10	2021-05-08	Efficacy and safety of antiplatelet drugs in patients with moyamoya disease after revascularization	Efficacy and safety of antiplatelet drugs in patients with moyamoya disease after revascularization	Moyamoya disease	Taking aspirin group:Nil;No aspirin group:Nil;	Qilu Hospital of Shandong University	NULL	Recruiting	0	60	Both	Taking aspirin group:105;No aspirin group:105;		china
5	JPRN-jRCTs031200402	23/04/2021	08/03/2021	Search for abnormalities of fundus blood vessels in moyamoya disease	Search for abnormalities of fundus blood vessels in moyamoya disease	Moyamoya disease Moyamoya disease	For fluoresceinfundus angiography, 500 mg of fluorescein(5 ml vial of aqueous solution containing 50 ...	Akiyama Hideo	NULL	Recruiting	>= 20age old	Not applicable	Both	50	N/A	Japan
6	ChiCTR2000041260	2021-01-01	2020-12-23	The effects of norepinephrine and phenylephrine on cerebral oxygenation in treating intraoperative h ...	The effects of norepinephrine and phenylephrine on cerebral oxygenation in treating intraoperative h ...	moyamoya disease	Group 1:iv norepinephrine;Group 2:iv phenylephrine;	The South District of Anhui Provincial Hospital	NULL	Recruiting	18	65	Both	Group 1:30;Group 2:30;	Phase 4	China
7	ChiCTR2000029878	2020-11-01	2020-02-16	The effects of norepinephrine and phenylephrine on cerebral oxygenation in treating intraoperative h ...	The effects of norepinephrine and phenylephrine on cerebral oxygenation in treating intraoperative h ...	moyamoya disease	Group 1:iv norepinephrine;Group 2:iv phenylephrine;	The South District of Anhui Provincial Hospital	NULL	Pending	18	65	Both	Group 1:30;Group 2:30;	Phase 4	China
8	NCT04205578 (ClinicalTrials.gov)	January 2020	18/12/2019	NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events	A Multi-center, Randomized, Single-blind, Placebo-controlled Study of Dl-3-n-butylphthalide in Patie ...	Moyamoya Disease;Ischemic Cerebral Infarction;Ischemic Stroke;Ischemic Cerebrovascular Accident;Tran ...	Drug: dl-3-n-butylphthalide (NBP);Drug: Normal Saline 0.9% Infusion Solution	yuanli Zhao	Peking University International Hospital	Not yet recruiting	18 Years	60 Years	All	450	Phase 3	China
9	NCT04012268 (ClinicalTrials.gov)	July 15, 2019	3/7/2019	The Safety and Efficacy of RIC on Adult Moyamoya Disease	The Safety and Effect of Remote Ischemic Conditioning on Adult Moyamoya Disease	Moyamoya Disease	Device: RIC;Drug: Aspirin	Capital Medical University	NULL	Completed	18 Years	60 Years	All	30	N/A	China
10	ChiCTR1900027197	2019-05-01	2019-11-04	Study on the protective effect of desflurane combined with propofol on the brain of patients with mo ...	Study for the protective effect of desflurane on the brain of patients with moyamoya disease	Moyamoya disease	Group D:Desflurane for anesthesia maintenance;GroupP:Propofol;GroupPD:Desflurane and propofol;	The First Affiliated Hospital of Zhengzhou University	NULL	Completed	20	65	Both	Group D:30;GroupP:30;GroupPD:30;	Phase 4	China

First Previous1 2Next Last